Shuttle Pharmaceuticals Holdings (SHPH) Net Income towards Common Stockholders (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Net Income towards Common Stockholders history runs 6 years deep, the most recent figure standing at -$2.2 million for Q1 2026.

• In Q1 2026, Net Income towards Common Stockholders rose 24.62% year-over-year to -$2.2 million; the TTM figure through Mar 2026 stood at -$11.2 million (down 31.4% YoY), while the FY2025 annual figure was -$11.9 million, down 55.54% from the prior year.
• Net Income towards Common Stockholders was -$2.2 million for Q1 2026 at Shuttle Pharmaceuticals Holdings, up from -$2.8 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of -$587079.0 in Q4 2024 to a low of -$4.4 million in Q4 2022.
• Historically, Net Income towards Common Stockholders has averaged -$2.1 million across 5 years, with a median of -$1.9 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Net Income towards Common Stockholders plunged 807.29% in 2022, then surged 64.21% in 2024.
• A 5-year view of Net Income towards Common Stockholders shows it stood at -$4.4 million in 2022, then jumped by 62.7% to -$1.6 million in 2023, then soared by 64.21% to -$587079.0 in 2024, then tumbled by 368.86% to -$2.8 million in 2025, then advanced by 19.03% to -$2.2 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$2.2 million (Q1 2026), -$2.8 million (Q4 2025), and -$2.3 million (Q3 2025), per Business Quant data.